A review of the literature for intra-arterial chemotherapy used to treat retinoblastoma

Research output: Contribution to journalArticle

Abstract

Retinoblastoma is a malignancy of the retina that usually presents before the age of 5 years. Sporadic retinoblastoma is most often unilateral and with no hereditary influence, whereas familial retinoblastoma presents unilaterally or bilaterally in conjunction with genetic inheritance. Several treatments have been attempted with the goals of saving the child’s life, salvaging the eye, and preserving vision. Alternative methods including external beam radiation, systemic chemotherapy and focal therapies have been shown to be effective but carry a risk of enucleation and other complications proportional to the severity of the tumor. Selective intra-arterial chemotherapy for retinoblastoma began in 1988 in Japan and has emerged in the last 7 years in the United States as a feasible, effective and minimally invasive treatment option. We review the retinoblastoma treatment literature focusing on intra-arterial chemotherapy.

Original languageEnglish (US)
Pages (from-to)1-11
Number of pages11
JournalPediatric Radiology
DOIs
StateAccepted/In press - Feb 17 2016

Fingerprint

Retinoblastoma
Drug Therapy
Therapeutics
Retina
Neoplasms
Japan
Radiation

Keywords

  • Children
  • International classification
  • Intra-arterial chemotherapy
  • Melphalan
  • Reese–Ellsworth classification
  • Retinoblastoma
  • Systemic chemotherapy

ASJC Scopus subject areas

  • Radiology Nuclear Medicine and imaging
  • Pediatrics, Perinatology, and Child Health

Cite this

@article{d1bc8fc5421c46c8a1a1b297c9a05d85,
title = "A review of the literature for intra-arterial chemotherapy used to treat retinoblastoma",
abstract = "Retinoblastoma is a malignancy of the retina that usually presents before the age of 5 years. Sporadic retinoblastoma is most often unilateral and with no hereditary influence, whereas familial retinoblastoma presents unilaterally or bilaterally in conjunction with genetic inheritance. Several treatments have been attempted with the goals of saving the child’s life, salvaging the eye, and preserving vision. Alternative methods including external beam radiation, systemic chemotherapy and focal therapies have been shown to be effective but carry a risk of enucleation and other complications proportional to the severity of the tumor. Selective intra-arterial chemotherapy for retinoblastoma began in 1988 in Japan and has emerged in the last 7 years in the United States as a feasible, effective and minimally invasive treatment option. We review the retinoblastoma treatment literature focusing on intra-arterial chemotherapy.",
keywords = "Children, International classification, Intra-arterial chemotherapy, Melphalan, Reese–Ellsworth classification, Retinoblastoma, Systemic chemotherapy",
author = "Emily Wyse and James Handa and Friedman, {Alan David} and Monica Pearl",
year = "2016",
month = "2",
day = "17",
doi = "10.1007/s00247-016-3554-6",
language = "English (US)",
pages = "1--11",
journal = "Pediatric Radiology",
issn = "0301-0449",
publisher = "Springer Verlag",

}

TY - JOUR

T1 - A review of the literature for intra-arterial chemotherapy used to treat retinoblastoma

AU - Wyse, Emily

AU - Handa, James

AU - Friedman, Alan David

AU - Pearl, Monica

PY - 2016/2/17

Y1 - 2016/2/17

N2 - Retinoblastoma is a malignancy of the retina that usually presents before the age of 5 years. Sporadic retinoblastoma is most often unilateral and with no hereditary influence, whereas familial retinoblastoma presents unilaterally or bilaterally in conjunction with genetic inheritance. Several treatments have been attempted with the goals of saving the child’s life, salvaging the eye, and preserving vision. Alternative methods including external beam radiation, systemic chemotherapy and focal therapies have been shown to be effective but carry a risk of enucleation and other complications proportional to the severity of the tumor. Selective intra-arterial chemotherapy for retinoblastoma began in 1988 in Japan and has emerged in the last 7 years in the United States as a feasible, effective and minimally invasive treatment option. We review the retinoblastoma treatment literature focusing on intra-arterial chemotherapy.

AB - Retinoblastoma is a malignancy of the retina that usually presents before the age of 5 years. Sporadic retinoblastoma is most often unilateral and with no hereditary influence, whereas familial retinoblastoma presents unilaterally or bilaterally in conjunction with genetic inheritance. Several treatments have been attempted with the goals of saving the child’s life, salvaging the eye, and preserving vision. Alternative methods including external beam radiation, systemic chemotherapy and focal therapies have been shown to be effective but carry a risk of enucleation and other complications proportional to the severity of the tumor. Selective intra-arterial chemotherapy for retinoblastoma began in 1988 in Japan and has emerged in the last 7 years in the United States as a feasible, effective and minimally invasive treatment option. We review the retinoblastoma treatment literature focusing on intra-arterial chemotherapy.

KW - Children

KW - International classification

KW - Intra-arterial chemotherapy

KW - Melphalan

KW - Reese–Ellsworth classification

KW - Retinoblastoma

KW - Systemic chemotherapy

UR - http://www.scopus.com/inward/record.url?scp=84958817834&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84958817834&partnerID=8YFLogxK

U2 - 10.1007/s00247-016-3554-6

DO - 10.1007/s00247-016-3554-6

M3 - Article

C2 - 26886915

AN - SCOPUS:84958817834

SP - 1

EP - 11

JO - Pediatric Radiology

JF - Pediatric Radiology

SN - 0301-0449

ER -